PASG – passage bio, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

PASG

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/31

09:56 am

pasg

Rating for PASG

High Report

Rating for PASG

Report

3/31

09:56 am

pasg

Rating for PASG

High Report

Rating for PASG

Report

3/31

08:41 am

pasg

Passage Bio (PASG) is now covered by Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $30.00 price target on the stock.

High Report

Passage Bio (PASG) is now covered by Oppenheimer Holdings, Inc.. They set an "outperform" rating and a $30.00 price target on the stock.

Report

3/30

04:07 pm

pasg

Passage Bio initiated with an Outperform at Oppenheimer

High Report

Passage Bio initiated with an Outperform at Oppenheimer

Report

3/30

04:07 pm

pasg

Passage Bio initiated with an Outperform at Oppenheimer

High Report

Passage Bio initiated with an Outperform at Oppenheimer

Report

3/4

02:00 pm

pasg

Rating for PASG

Low Report

Rating for PASG

Report

2/10

08:03 am

pasg

Passage Bio (NASDAQ:PASG) is now covered by analysts at Chardan Capital. They set a "buy" rating and a $21.00 price target on the stock.

Low Report

Passage Bio (NASDAQ:PASG) is now covered by analysts at Chardan Capital. They set a "buy" rating and a $21.00 price target on the stock.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.